Supplements · Diets
dietary flaxseed decreases blood pressure
In plain terms: Does eating ground flaxseed daily lower blood pressure?
Whole milled flaxseed produces a small-to-moderate real BP reduction, largest in hypertensives (the FLAX-PAD trial is a standout). But the effect is form- and endpoint-dependent — flaxseed-OIL trials are weaker and often null on diastolic BP — so overall it's a modest, not uniformly robust, dietary effect.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Whole milled flaxseed produces a small-to-moderate real blood-pressure reduction, largest in people who are already hypertensive, where the FLAX-PAD trial cut central aortic pressure by roughly 10 over 6 mmHg. The effect is less clear elsewhere: trials in diabetic and normotensive-to-stage-1 populations are underpowered or uncertain, and flaxseed oil is weaker than the whole seed.
The evidence (17)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Nie Y, Wang Y, Hui J, Shao D, Chen R, Deng Q, Chen Y, Wang X, Zhu D 2025 · Nutrients | observational | supports | low | Human-centric evidence grading of 13 flaxseed oil trials rated the evidence body for blood pressure as grade B, concluding flaxseed oil intervention significantly decreases blood pressure (no pooled mmHg figure given); duration/dose not spe |
| Caligiuri SP, Rodriguez-Leyva D, Aukema HM, Ravandi A, Weighell W, Guzman R, Pierce GN 2016 · Hypertension | RCT | supports | moderate | In the same FLAX-PAD cohort, flaxseed reduced central aortic SBP/DBP by ~10/6 mmHg in baseline-hypertensive patients, mediated by changes in plasma oxylipins. |
| Musazadeh V, Nezamoleslami S, Faghfouri AH, Shidfar F, Aryaeian N 2025 · Diabetes Metab Syndr | meta-analysis | tested-null | low | Random-effects MA of 16 RCTs (1136 diabetic patients), SMD scale. Underpowered trend on blood pressure: systolic SMD -0.50 (95% CI -1.25 to 0.25), p=0.193; diastolic SMD -0.74 (-1.51 to 0.03), p=0.060; I2 ~88%. Authors: flaxseed 'does not suggest any benefit on blood pressure'. Point estimates favour lowering but intervals include zero. (Abstract prints these without leading minus signs; p-values fix the signs.) |
| McNabb TB, Young I, Newman RG, Skinner RC, Benedito VA, Tou JC 2024 · Curr Hypertens Rev | meta-analysis | contradicts | moderate | Flaxseed and olive oil supplementation showed uncertain/limited BP effects in normo- to stage-1 hypertensive adults. |
| Yin S, Xu H, Xia J, Lu Y, Xu D, Sun J, Wang Y, Liao W, Sun G 2023 · Adv Nutr | meta-analysis | mixed | moderate | ALA supplementation (mainly flaxseed) modestly lowered SBP and CRP but had no significant effect on DBP and raised LDL, with benefit concentrated at 3+ g/day for 12+ weeks. |
| Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X 2009 · Am J Clin Nutr | meta-analysis | mixed | moderate | Flaxseed interventions modestly improved blood lipids (context for CVD-risk claim) with effects varying by product type and sex. |
| Rodriguez-Leyva D, Weighell W, Edel AL, LaVallee R, Dibrov E, Pinneker R, Maddaford TG, Ramjiawan B, Aliani M, Guzman R, Pierce GN 2013 · Hypertension | RCT | supports | high | In PAD patients, 30g/day milled flaxseed for 6 months lowered SBP ~10 and DBP ~7 mmHg vs placebo, with a 15/7 mmHg reduction in those hypertensive at baseline. ↩ SUPERSEDED — pooled in the review above, counted once |
| Sala-Vila A, Fleming J, Kris-Etherton P, Ros E 2022 · Adv Nutr | observational | supports | low | Review reports ALA-rich foods including flaxseed reduce blood pressure and other CVD risk factors in trials and cohorts. |
| Fazeli Moghadam E, Khaghani L, Shekarchizadeh-Esfahani P 2024 · Clinical nutrition research | meta-analysis | supports | moderate | Meta-analysis of 5 RCTs in hypertensive subjects found flaxseed supplementation significantly reduced systolic BP by 8.64 mmHg (95% CI -15.41 to -1.87) and diastolic BP by 4.87 mmHg (95% CI -8.37 to -1.37); duration not specified in abstrac |
| Kunutsor SK, Jassal DS, Ravandi A, Lehoczki A 2025 · GeroScience | observational | supports | moderate | Narrative review synthesizing flaxseed cardiometabolic trials reports BP reductions of ~2-15 mmHg systolic and 1-7 mmHg diastolic, with optimal benefit at ≥30 g/day ground whole flaxseed for ≥12 weeks. |
| Jafarpour A, Ostovan VR, Akhlaghi M 2026 · The Journal of nutrition | RCT | contradicts | moderate | 68 migraine patients took 20 g/d flaxseed powder vs roasted wheat powder for 8 weeks; blood pressure was a secondary outcome and changes were not significant between groups. |
| Toulabi T, Yarahmadi M, Goudarzi F, Ebrahimzadeh F, Momenizadeh A, Yarahmadi S 2022 · Explore | RCT | supports | moderate | In hypertensive patients, flaxseed supplementation significantly reduced blood pressure, BMI, and total cholesterol versus control. |
| Mahmudiono T, Jasim SA, Karim YS, Bokov DO, Abdelbasset WK, Akhmedov KS, Yasin G, Thangavelu L, Mustafa YF, Shoukat S, Najm MAA, Amraei M 2022 · Phytother Res | meta-analysis | mixed | moderate | Flaxseed oil reduced systolic but not diastolic BP in metabolic-syndrome patients across pooled RCTs. |
| Musazadeh V, Hamidi N, Mahmoudinezhad M, Jafari A, Shidfar F 2025 · Journal of diabetes and metabolic disorders | meta-analysis | supports | high | Meta-analysis of 18 RCTs (22 arms, 1,209 participants) found flaxseed supplementation reduced systolic BP by 4.30 mmHg (95% CI -6.64 to -1.96) and diastolic BP by 2.50 mmHg (95% CI -3.88 to -1.12); larger effects with 10-20 week duration, w |
| Khalesi S, Irwin C, Schubert M 2015 · J Nutr | meta-analysis | supports | moderate | Pooled controlled trials found flaxseed consumption reduced blood pressure, with larger effects for whole-seed and longer interventions. |
| Li L, Li H, Gao Y, Vafaei S, Zhang X, Yang M 2023 · Food and Function | meta-analysis | supports | high | Pooled analysis of 33 trials (2427 participants) found flaxseed supplementation significantly reduced SBP by ~3.2 mmHg, a real but smaller aggregate effect than the flagship single trial. |
| Hasan R, Saleh RO, Raheema RH, Hulail HM, Ahmad I, Nathiya D, Kaur P 2025 · Journal of cardiovascular and thoracic research | meta-analysis | supports | moderate | Meta-analysis of 18 RCTs in patients with cardiovascular risk factors found flaxseed supplementation reduced systolic BP by 4.75 mmHg (95% CI -7.05 to -2.44) and diastolic BP by 3.09 mmHg (95% CI -4.37 to -1.81); high heterogeneity (I2>90%) |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.